Concepedia

Daniel S. Spellman

DS

26

Publications

1.6K

Citations

20

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

New York University

Janssen (United States)

Janssen (Belgium)

Daniel S. Spellman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and neuroscience.

Top concepts

MedicineImmunologyNeurosciencePharmacologyAllergyVirologyBioanalysisVaccinationVaccinologyAutoimmunity

Publications per year

2004–2023

26

Publications

26

Neuronal Growth Cone Retraction Relies on Proneurotrophin Receptor Signaling Through Rac

Katrin Deinhardt, Taeho Kim, Daniel S. Spellman et al. · Science Signaling · 2011 · 185 citations

Cytoskeleton, Neurotransmission, Cell Growth +18

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

Daniel S. Spellman, Kristin R. Wildsmith, Lee Honigberg et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2015 · 158 citations · Full text

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 145 citations · Full text

Respiratory Virus Immunity, Viral Immunity, Immunology +19

Stable Isotopic Labeling by Amino Acids in Cultured Primary Neurons

Daniel S. Spellman, Katrin Deinhardt, Costel C. Darie et al. · Molecular & Cellular Proteomics · 2008 · 120 citations · Full text

Amino Acids, Biochemistry, Neurophysiology +12

Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease

Ondrej Libiger, Leslie M. Shaw, Mark H. Watson et al. · Alzheimer s & Dementia · 2021 · 116 citations · Full text

Rows per page

1–5 of 26